4//SEC Filing
Schobel Alexander Mark 4
Accession 0001214659-24-004389
CIK 0001398733other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 1:45 PM ET
Size
7.1 KB
Accession
0001214659-24-004389
Insider Transaction Report
Form 4
Schobel Alexander Mark
Chief Innovation/Tech Officer
Transactions
- Tax Payment
Common Stock
2024-03-09$4.88/sh−5,895$28,768→ 1,034,476 total - Sale
Common Stock
2024-03-08$5.19/sh−25,000$129,685→ 1,040,371 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4 on December 16, 2023.
- [F2]Represents the weighted average sales price per share. The shares sold at prices ranging from $5.00 to $5.60 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F3]Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.
Documents
Issuer
Aquestive Therapeutics, Inc.
CIK 0001398733
Entity typeother
Related Parties
1- filerCIK 0001406836
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 1:45 PM ET
- Size
- 7.1 KB